A NEW APPROACH WITH LESS DAMAGE: INTRANASAL DELIVERY OF TETRACYCLINE-INDUCIBLE REPLICATION-DEFECTIVE HERPES SIMPLEX VIRUS TYPE-1 VECTOR TO BRAINJIANG, Y; WEI, N; ZHU, J et al.Neuroscience. 2012, Vol 201, pp 96-104, issn 0306-4522, 9 p.Article

Oral lactoferrin prevents body weight loss and increases cytokine responses during herpes simplex virus type 1 infection of miceWAKABAYASHI, Hiroyuki; KUROKAWA, Masahiko; SHIN, Kouichirou et al.Bioscience, biotechnology, and biochemistry. 2004, Vol 68, Num 3, pp 537-544, issn 0916-8451, 8 p.Article

Psychological stress impairs the local CD8⁺ T cell response to mucosal HSV-1 infection and allows for increased pathogenicity via a glucocorticoid receptor-mediated mechanismASHCRAFT, Kathleen A; HUNZEKER, John; BONNEAU, Robert H et al.Psychoneuroendocrinology. 2008, Vol 33, Num 7, pp 951-963, issn 0306-4530, 13 p.Article

Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activityCORTESI, R; ARGNANI, R; MENEGATTI, E et al.International journal of pharmaceutics. 2006, Vol 317, Num 1, pp 90-100, issn 0378-5173, 11 p.Article

Engineering Cell Lines for Production of Replication Defective HSV-1 Gene Therapy VectorsGRANT, Kyle G; KRISKY, David M; ATAAI, Mohammed M et al.Biotechnology and bioengineering. 2009, Vol 102, Num 4, pp 1087-1097, issn 0006-3592, 11 p.Article

Production of recombinant gG-1 protein of herpes simplex virus type 1 in a prokaryotic system in order to develop a type-specific enzyme-linked immunosorbent assay kitZANDI, Keivan; MOHAMMAD HASSAN ROOSTAEE; SADEGHIZADEH, Majid et al.FEMS immunology and medical microbiology. 2007, Vol 50, Num 3, pp 319-323, issn 0928-8244, 5 p.Article

Inhibitory activity and mechanism of two scorpion venom peptides against herpes simplex virus type 1WEI HONG; TIAN LI; YU SONG et al.Antiviral research. 2014, Vol 102, pp 1-10, issn 0166-3542, 10 p.Article

Antiviral activity of Bignoniaceae species occurring in the State of Minas Gerais (Brazil): part 1BRANDAO, G. C; KROON, E. G; DOS SANTOS, J. R et al.Letters in applied microbiology. 2010, Vol 51, Num 4, pp 469-476, issn 0266-8254, 8 p.Article

Genetic engineering of a modified herpes simplex virus 1 vaccine vectorXUEQIAO LIU; EEVA BROBERG; WATANABE, Daisuke et al.Vaccine. 2009, Vol 27, Num 21, pp 2760-2767, issn 0264-410X, 8 p.Article

Evaluation of γ-interferon kinetics in HSV-1 infected mice in different days post infection (in vivo) and post re-stimulation (in vitro)AREFIAN, Ehsan; BAMDAD, Travat; SOLEIMANJAHI, Hoorieh et al.Comparative immunology, microbiology and infectious diseases. 2007, Vol 30, Num 1, pp 1-9, issn 0147-9571, 9 p.Article

A mutant deleted for most of the herpes simplex virus type 1 (HSV-1) UOL gene does not affect the spontaneous reactivation phenotype in rabbitsCHAN, David; COHEN, Jacob; NAITO, Julie et al.Journal of neurovirology. 2006, Vol 12, Num 1, pp 5-16, issn 1355-0284, 12 p.Article

Elevated PrPC expression predisposes to increased HSV-1 pathogenicityTHACKRAY, Alana M; BUJDOSO, Raymond.Antiviral chemistry & chemotherapy. 2006, Vol 17, Num 1, pp 41-52, issn 0956-3202, 12 p.Article

The stability of herpes simplex virus type I genomes in infected Vero cells undergoing viral induced apoptosisSU, Ying-Hsiu; XIANCHAO ZHANG; AIAMKITSUMRIT, Benjamas et al.Journal of neurovirology. 2006, Vol 12, Num 5, pp 375-386, issn 1355-0284, 12 p.Article

Development of a recombinant Leishmania major strain sensitive to ganciclovir and 5-fluorocytosine for use as a live vaccine challenge in clinical trialsDAVOUDI, Noushin; TATE, Celia A; WARBURTON, Corinna et al.Vaccine. 2005, Vol 23, Num 9, pp 1170-1177, issn 0264-410X, 8 p.Article

Significance of amino acid substitutions in the thymidine kinase gene of herpes simplex virus type 1 for resistanceSAUERBREI, Andreas; LIERMANN, Kristin; BOHN, Kathrin et al.Antiviral research. 2012, Vol 96, Num 2, pp 105-107, issn 0166-3542, 3 p.Article

Impaired functioning in euthymic patients with bipolar disorder — HSV-1 as a predictorGERBER, Sonja I; KRIENKE, Ute J; BIEDERMANN, Nane-Christine et al.Progress in neuro-psychopharmacology & biological psychiatry. 2012, Vol 36, Num 1, pp 110-116, issn 0278-5846, 7 p.Article

IL-29/IL-28A suppress HSV-1 infection of human NT2-N neuronsLIN ZHOU; JIELIANG LI; XU WANG et al.Journal of neurovirology. 2011, Vol 17, Num 3, pp 212-219, issn 1355-0284, 8 p.Article

Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1ADVANI, S. J; MARKERT, J. M; SOOD, R. F et al.Gene therapy (Basingstoke). 2011, Vol 18, Num 11, pp 1098-1102, issn 0969-7128, 5 p.Article

Control of HSV-1 latency in human trigeminal ganglia—current overviewHELD, Kathrin; DERFUSS, Tobias.Journal of neurovirology. 2011, Vol 17, Num 6, pp 518-527, issn 1355-0284, 10 p.Article

Virostatic potential of micro-nano filopodia-like ZnO structures against herpes simplex virus-1MISHRA, Yogendra Kumar; ADELUNG, Rainer; RÖHL, Claudia et al.Antiviral research. 2011, Vol 92, Num 2, pp 305-312, issn 0166-3542, 8 p.Article

Expression, purification of the UL3 protein of herpes simplex virus type 1, and production of UL3 polyclonal antibodyFUSEN LIN; XIAOMING REN; HONG GUO et al.Journal of virological methods. 2010, Vol 166, Num 1-2, pp 72-76, issn 0166-0934, 5 p.Article

Targeting human glioma cells using HSV-1 amplicon peptide display vectorHO, Iaw; MIAO, L; SIA, K. C et al.Gene therapy (Basingstoke). 2010, Vol 17, Num 2, pp 250-260, issn 0969-7128, 11 p.Article

Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1 infectivityGALDIERO, Stefania; FALANGA, Annarita; VITIELLO, Mariateresa et al.Peptides (New York, NY. 1980). 2008, Vol 29, Num 9, pp 1461-1471, issn 0196-9781, 11 p.Article

Discriminant analysis of DNA polymorphisms in herpes simplex virus type 1 strains involved in primary compared to recurrent infectionsUMENE, Kenichi; KOGA, Chihiro; KAMEYAMA, Tadamitsu et al.Journal of virological methods. 2007, Vol 139, Num 2, pp 159-165, issn 0166-0934, 7 p.Article

Enhanced antiglioma activity of chimeric HCMV/HSV-1 oncolytic virusesSHAH, A. C; PARKER, J. N; GILLESPIE, G. Y et al.Gene therapy (Basingstoke). 2007, Vol 14, Num 13, pp 1045-1054, issn 0969-7128, 10 p.Article